当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 现金流量表

海翔药业

(002099)

  

流通市值:86.82亿  总市值:86.93亿
流通股本:16.17亿   总股本:16.19亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金676,227,167.15348,382,709.371,307,638,032.44993,992,352.52
  收到的税费返还54,793,848.7523,627,173.94112,760,632.65100,327,020.66
  收到其他与经营活动有关的现金67,533,261.0538,130,111.93169,769,566.36133,469,750.34
  经营活动现金流入小计798,554,276.95410,139,995.241,590,168,231.451,227,789,123.52
  购买商品、接受劳务支付的现金396,793,075.84265,801,663.621,016,927,065.45754,301,089.48
  支付给职工以及为职工支付的现金184,347,326100,717,738.13341,911,428.04253,652,609.17
  支付的各项税费57,849,101.5430,038,410.4677,788,458.2882,641,878.02
  支付其他与经营活动有关的现金121,555,133.9966,547,691.31213,219,648.23120,235,960.96
  经营活动现金流出小计760,544,637.37463,105,503.521,649,846,6001,210,831,537.63
  经营活动产生的现金流量净额38,009,639.58-52,965,508.28-59,678,368.5516,957,585.89
二、投资活动产生的现金流量:
  收回投资收到的现金7,057,540.65-37,956,771.13130,489.88
  取得投资收益收到的现金10,232,455.7710,211,171.548,842,850.517,272,551.35
  处置固定资产、无形资产和其他长期资产收回的现金净额113,493.612,287.69,248,067.72117,441.3
  收到的其他与投资活动有关的现金16,846,467.441,478,586.32408,738,837.93419,327,624.71
  投资活动现金流入小计34,249,957.4611,702,045.46464,786,527.29426,848,107.24
  购建固定资产、无形资产和其他长期资产支付的现金38,806,371.3125,679,025.2874,460,780.8661,784,910.28
  投资支付的现金--51,238,562-
  支付其他与投资活动有关的现金184,607,370.13120,625,795.9531,459,127.99311,375,983.19
  投资活动现金流出小计223,413,741.44146,304,821.23157,158,470.85373,160,893.47
  投资活动产生的现金流量净额-189,163,783.98-134,602,775.77307,628,056.4453,687,213.77
三、筹资活动产生的现金流量:
  取得借款收到的现金802,860,626.96230,000,0002,452,690,0001,777,230,000
  收到其他与筹资活动有关的现金62,406,00033,706,000247,140,000205,440,000
  筹资活动现金流入小计865,266,626.96263,706,0002,699,830,0001,982,670,000
  偿还债务支付的现金809,530,000442,530,0002,391,200,0001,771,200,000
  分配股利、利润或偿付利息支付的现金12,163,194.966,239,854.7226,292,992.8518,755,203.69
  支付其他与筹资活动有关的现金234,571,661.55125,288,739.6179,313,371.73147,305,569.42
  筹资活动现金流出小计1,056,264,856.51574,058,594.322,596,806,364.581,937,260,773.11
  筹资活动产生的现金流量净额-190,998,229.55-310,352,594.32103,023,635.4245,409,226.89
四、汇率变动对现金及现金等价物的影响-27,887,080.29-17,351,551.77-29,127,288.64-5,527,511.7
五、现金及现金等价物净增加额-370,039,454.24-515,272,430.14321,846,034.67110,526,514.85
  加:期初现金及现金等价物余额1,257,974,352.091,257,974,352.09936,128,317.42936,128,317.42
  期末现金及现金等价物余额887,934,897.85742,701,921.951,257,974,352.091,046,654,832.27
补充资料:
  净利润-64,502,728.52--93,754,370.28-
  资产减值准备78,279,635.18-105,382,349.41-
  固定资产和投资性房地产折旧158,826,473.43-316,492,335.73-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧158,826,473.43-316,492,335.73-
  无形资产摊销8,167,019.64-19,705,794.29-
  长期待摊费用摊销549,470.05-1,577,469.04-
  处置固定资产、无形资产和其他长期资产的损失-131,922.5--31,936.39-
  固定资产报废损失-1,068,194.05--1,572,736.63-
  公允价值变动损失-3,253,099.03-14,790,765.56-
  财务费用47,164,125.04-53,376,284.79-
  投资损失-51,613,415.22--55,820,826.72-
  递延所得税-4,948,525.17-3,577,921.96-
  其中:递延所得税资产减少-13,940,726.54--397,968.49-
    递延所得税负债增加8,992,201.37-3,975,890.45-
  存货的减少-62,585,711.67--186,963,223.17-
  经营性应收项目的减少-135,194,380.96--163,714,681.23-
  经营性应付项目的增加66,170,166.21--77,676,548.92-
  现金的期末余额887,934,897.85-1,257,974,352.09-
  减:现金的期初余额1,257,974,352.09-936,128,317.42-
  现金及现金等价物的净增加额-370,039,454.24-321,846,034.67-
公告日期2026-08-292026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑